Deals review
- Deals review
- Deal details
ALLIANCE BOOTS COMPLETES JOINT VENTURE IN CHINA
In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Related deals
Alliance Boots to enter Chinese pharmaceutical market through joint venture
Alliance Boots acquires megapharm in Germany
Alliance Boots completes acquisition of Depolabo
Completion of Boots Opticians merger with Dollond & Aitchison
SOLVAY AND HUATAI TO JOINTLY BUILD HYDROGEN PEROXIDE PLANT IN CHINA
BRACCO CONSOLIDATES OPERATIONS IN CHINA A NEW JOINT VENTURE WITH SINE IN SHANGHAI
Boots Opticians to merge with Dollond & Aitchison
Natrol, Inc. Enters into Joint Venture for China
Related categories
- Therapeutic target
- Cardiovascular
- Industry sector
- Pharmaceutical
More deals
Latest deals
- Biovator and BASF sign technology development agreement
- Agfa HealthCare signs four-year agreement with Chinese partners for distribution of radiography solutions, potentially worth 500 million US dollar
- Omnicare Announces Acquisition of Continuing Care Rx
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program
Most viewed deals
- Recommended acquisition of Acambis plc ("Acambis") by Sanofi Pasteur Holding ("Sanofi Pasteur") by way of scheme of arrangement Posting of Scheme Document
- Omnicare Announces Acquisition of Continuing Care Rx
- Bayer CropScience and Janssen PMP conclude research agreement:
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- Biovator and BASF sign technology development agreement
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us